"Unwarranted variation" from_date:2012

244 resultsPro users have access to +22 Systematic Reviews

Filter Results
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
                    • Pro

                            Clinical Area Pro

                            Further Refinement
                            User Guide

                            User Guide

                            1
                            2019Sax Institute Evidence Check
                            Addressing unwarranted variation in healthcare Addressing unwarranted variation in healthcare An Evidence Check rapid review brokered by the Sax Institute for Cancer Institute NSW. March 2019 An Evidence Check rapid review brokered by the Sax Institute for Cancer Institute NSW. March 2019. This report was prepared by: Reema Harrison, Elizabeth Manias, Steven Mears, Reece Hinchcliff this report may be directed to the: Principal Analyst Knowledge Exchange Program Sax Institute www.saxinstitute.org.au knowledge.exchange@saxinstitute.org.au Phone: +61 2 91889500 Suggested Citation: Harrison R, Manias E, Mears S, Hinchcliff R, Heslop D. Addressing unwarranted variation in healthcare: an Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for Cancer
                            2
                            2023PLoS ONE
                            Did the evidence-based intervention (EBI) programme reduce inappropriate procedures, lessen unwarranted variation or lead to spill-over effects in the National Health Service? Health systems are under pressure to maintain services within limited resources. The Evidence-Based Interventions (EBI) programme published a first list of guidelines in 2019, which aimed to reduce inappropriate use
                            Subscribe to Trip PRO for an enhanced experience
                            • Access to millions of Full-text articles where avaliable
                            • Unlock 100,000+ extra articles with Systematic Reviews
                            • Further Filtering Options
                            • No adverts
                            • Advanced Search Ability
                            • Enhanced SmartSearch showing unlimited related articles
                            Read more about Trip PRO
                            3
                            2024Anaesthesia
                            Unwarranted variation and the goal of net zero for the NHS in England: exploring the link between efficiency working, patient outcomes and carbon footprint. In 2020 the NHS in England set a target of reaching net zero carbon emissions by 2040. Progress has already been made towards this goal, with substantial reductions in the use of environmentally harmful anaesthetic gases, such as desflurane , in recent years. Where an effective replacement already exists, changing practice to use low carbon alternatives is relatively easy to achieve, but much greater challenges lie ahead. The Getting It Right First Time (GIRFT) programme is a clinically-led, data-driven clinical improvement initiative with a focus on reducing unwarranted variation in clinical practice and patient outcomes. Reducing unwarranted
                            4
                            2022Academic Medicine
                            Will Any Road Get You There? Examining Warranted and Unwarranted Variation in Medical Education. Undergraduate and graduate medical education have long embraced uniqueness and variability in curricular and assessment approaches. Some of this variability is justified (warranted or necessary variation), but a substantial portion represents unwarranted variation. A primary tenet of outcomes-based medical education is ensuring that all learners acquire essential competencies to be publicly accountable to meet societal needs. Unwarranted variation in curricular and assessment practices contributes to suboptimal and variable educational outcomes and, by extension, risks graduates delivering suboptimal health care quality. Medical education can use lessons from the decades of study on unwarranted
                            5
                            Early Findings on the Use of Clinical Pathways for Management of Unwarranted Variation in Cancer Care. Clinical pathways have the potential to improve complex clinical decision-making in cancer care. The authors implemented pathways with customized content to assist oncologists to select treatments, aiming for an on-pathway rate of 70%-85%. Treatment decisions were captured as on or off pathway . Clinical pathways resulted in greater uniformity in medical oncology practice. Monthly feedback about usage, familiarity with the electronic platform, and regular content updates are some factors that may influence on-pathway rates. Clinical pathways hold promise to manage unwarranted variation in cancer care.
                            6
                            Understanding unwarranted variation in clinical practice: a focus on network effects, reflective medicine and learning health systems. In the past decades, extensive research has been performed on the phenomenon of unwarranted clinical variation in clinical practice. Many studies have been performed on signaling, describing and visualizing clinical variation. We argue that it is time for next and objective criteria for treatment choices. By combining these different concepts, alternative research objectives and new targets for improving and reducing unwarranted variation may be defined. In this perspective, we reflect on these concepts and propose target points for future research.
                            7
                            Settled science or unwarranted variation in local anesthetic dosing? An analysis from an International Registry of Regional Anesthesiology. Variation in clinical practice is often considered unwarranted when it does not reflect patient preference or evidence-based medicine. Complications from regional anesthesia such as nerve injury and systemic toxicity are dose dependent. It is currently
                            8
                            Medical care epidemiology and unwarranted variation: the Israeli case In an article in this Journal, Mendlovic and colleagues report on regional variation in medical care across Israeli regions. This study joins a growing literature demonstrating generally high variation in the provision of health care services within developed countries. This commentary summarizes the status of medical care epidemiology and its studies of unwarranted variation in health care, and provides a conceptual framework to guide future studies. Recommendations are offered for advancing studies in Israel that could guide policy development and clinical improvement.
                            9
                            Addressing unwarranted variations in colorectal cancer outcomes: a conceptual approach. In the clinical setting, the term 'unwarranted variation' refers to variations in patient outcomes that cannot be explained by the patient's underlying illness or medical needs, or the dictates of evidence-based medicine. These types of variations persist even after adjusting for patient-specific factors . Unwarranted variation depends on a complex mix of disparities, including inequalities in access to appropriate care in a wide variety of geographical and cultural settings, in the uptake and application of clinical knowledge, in the prioritization and allocation of resources, and differences in organizational and professional culture. Nevertheless, unwarranted variation has been inexorably linked
                            10
                            2016Journal of Clinical Oncology
                            Unwarranted variation in time to initiation of adjuvant chemotherapy in a statewide collaborative.
                            11
                            12
                            2013American Journal of Medicine
                            Does Clinical Decision Support Reduce Unwarranted Variation in Yield of CT Pulmonary Angiogram?
                            13
                            2013British Journal of Dermatology
                            Systemic psoriasis therapy shows high between-countries variation. A sign of unwarranted variation? Cross-sectional analysis of baseline data from the Psonet registries.
                            16
                            2025NIHR Evidence
                            ' assessment of the Evidence Based Interventions programme: Glynn J, and others. Did the evidence-based intervention (EBI) programme reduce inappropriate procedures, lessen unwarranted variation or lead to spill-over effects in the National Health Service? PLoS ONE 2023; 18: e0290996. Funding:NIHR Applied Research Collaboration (ARC) West. Conflicts of Interest:None declared. Disclaimer:Summaries on NIHR
                            17
                            2025American Urological Association
                            Trip Score
                            NarrativeNarrative based
                            EvidenceEvidence based
                            ?
                            18
                            2023Royal College of Nursing
                            Trip Score
                            NarrativeNarrative based
                            EvidenceEvidence based
                            ?
                            a programme of work in response to members’ concerns about the conduct of aseptic technique. These relate to reports of wide and unwarranted variation in clinical practice and education. The findings from this work support the RCN’s vision to lead and influence clinical nursing practice through health education, learning and development. This report adds to the profession’s education journey to enhance
                            19
                            2023Royal College of Paediatrics and Child Health
                            Trip Score
                            NarrativeNarrative based
                            EvidenceEvidence based
                            ?
                            . There are no current national guidelines to support the best management of this condition and clinical practice varies. The aim of this clinical practice guideline is to reduce unwarranted variation for the initial management of IgAV in children and young people. The complications associated with IgAV, including acute GI complications, are covered within a parallel document. The audience for this guideline
                            20
                            2024NHS England
                            prescribed in primary careDocument first published:12 March 2024Page updated:12 March 2024Topic:Commissioning, Medicine, Primary carePublication type:GuidanceThis is issued as general guidance under section 14Z51 of the NHS Act 2006 to reduce unwarranted variation, improve patient outcomes and provide value for money for the NHS. It provides recommendations for items that are available over the counter